Reviewed

custom peptides

Waiver type - Procurement: Nonavailability

Agency: NATIONAL INSTITUTES OF HEALTH (7529) • Product Service Code (PSC) : 6505 | Last Modified: 08/16/2023

Procurement Summary

KareBay Biochem Inc, https://www.karebaybio.com/, custom synthesized peptides to determine the immunity from T cells in rhesus macaques against segments of the Oropouche virus, 1mg of 15 AA peptide, 95% purity, quantity 408, including shipping and handling.

Waiver Rationale Summary

If this waiver is granted for AMBIS 2175814, research will be performed to develop vaccines to determine the immunity from T cells in rhesus macaques against segments of the Oropouche virus.

Did / Will the solicitation include one of the standard BAA provisions announcing the agency’s intention to provide a price preference for domestic end products and construction material?

Yes

Was a sources sought or Request for Information issued?

OMB Determination

Consistent with Policy

Product

DRUGS AND BIOLOGICALS

NAICS

541380 - Testing Laboratories

Date Submitted

07/31/2023

Procurement Instrument Identifier (PIID)

Solicitation ID

RFQ-NIAID-23-2175814

Procurement Stage

Post-solicitation

Expected Maximum Duration of the Proposed Waiver

Between 6 months and 1 year

Waiver Coverage

Individual Waiver

Funding Agency

NATIONAL INSTITUTES OF HEALTH